Paratek Pharmaceuticals I... (PRTK)
NASDAQ: PRTK
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM
Paratek Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
| Product Revenue | 136.82M | 106.08M | 38.75M | 11.52M |
| Product Revenue Growth | +28.97% | +173.74% | +236.49% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 36.26M | 33.49M | 53.81M | 33.85M | 30.34M | 27.6M | 43.98M | 25.95M | 27.11M | 22.36M | 24.34M | 20.9M | 20.98M | 23.64M | 21.26M | 23.64M | 20.92M | 23.32M | 25.26M | 13.61M | 12.91M | 11.87M | 11.66M | 8.22M | 8.72M | 8.36M | 6.5M | 5.95M | 7.6M | 6.34M | 5.64M | 5.79M | 4.28M | 4.27M |
| Selling, General, and Administrative Revenue Growth | +8.29% | -37.77% | +59.00% | +11.57% | +9.90% | -37.25% | +69.46% | -4.25% | +21.23% | -8.14% | +16.45% | -0.35% | -11.27% | +11.18% | -10.05% | +12.98% | -10.28% | -7.71% | +85.62% | +5.41% | +8.75% | +1.78% | +41.93% | -5.70% | +4.22% | +28.58% | +9.33% | -21.74% | +19.92% | +12.37% | -2.66% | +35.37% | +0.23% | n/a |
| Research and Development Revenue | 8.77M | 7.31M | 14.27M | 8.49M | 7.59M | 7.48M | 10.38M | 7.92M | 6.52M | 5.54M | 6.29M | 6.69M | 4.56M | 6.39M | 9.13M | 8.35M | 10.68M | 11.39M | 11.8M | 16.04M | 14.8M | 14.86M | 14.22M | 12.11M | 15.08M | 18.66M | 19.7M | 17.33M | 22.14M | 24.29M | 15.21M | 17.82M | 11M | 6.74M |
| Research and Development Revenue Growth | +20.03% | -48.78% | +68.14% | +11.78% | +1.52% | -27.93% | +31.01% | +21.49% | +17.71% | -11.90% | -6.00% | +46.61% | -28.61% | -30.04% | +9.38% | -21.81% | -6.26% | -3.47% | -26.42% | +8.36% | -0.42% | +4.49% | +17.45% | -19.68% | -19.18% | -5.31% | +13.67% | -21.69% | -8.86% | +59.69% | -14.64% | +62.00% | +63.15% | n/a |